Heart failure, aging and beta-blockers: The need for more data on tolerability and efficacy

Clinical Research in Cardiology

Volumn 97, Issue 9, 2008, Pages 575-577

  Damman, Kevin ^a   De Boer, Rudolf A ^a   Van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; NEBIVOLOL;

AGING; CLINICAL TRIAL; COMORBIDITY; DRUG EFFICACY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; MORBIDITY; MORTALITY; QUALITY OF LIFE; SINUS RHYTHM; TREATMENT FAILURE;

ADRENERGIC BETA-ANTAGONISTS; AGE DISTRIBUTION; DRUG TOLERANCE; HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 51349105220     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0680-7     Document Type: Editorial

References (21)

1. M Bohm N Werner M Kindermann 2006 Drug treatment of chronic heart failure Clin Res Cardiol 95 Suppl 4 36 54
2. D Dobre DJ van Veldhuisen G Mordenti 2007 Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the study of the effects of nebivolol intervention on outcomes and rehospitalisation in seniors with heart failure (SENIORS) trial Am Heart J 154 109 115
3. Düngen H, Krackhardt F, Apostolovic S, et al. (2008) Bisoprolol vs. Carvedilol in elderly patients with heart failure: rationale and desing of the CIBIS-ELD. Clin Res Cardiol This Issue
4. I Edes Z Gasior K Wita 2005 Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study Eur J Heart Fail 7 631 639
5. MD Flather MC Shibata AJ Coats 2005 Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 215 225
6. HL Hillege WH van Gilst DJ van Veldhuisen 2003 Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial Eur Heart J 24 412 420
7. T Jaarsma MH van der Wal I Lesman-Leegte 2008 Effect of moderate or intensive disease management program on outcome in patients with heart failure: coordinating study evaluating outcomes of advising and counseling in heart failure (COACH) Arch Intern Med 168 316 324
8. J Kjekshus E Apetrei V Barrios 2007 Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2248 2261
9. M Komajda P Lapuerta N Hermans 2005 Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey Eur Heart J 26 1653 1659
10. D Kovacic M Marinsek L Gobec M Lainscak M Podbregar 2008 Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure Clin Res Cardiol 97 24 31
11. H Krum J Hill F Fruhwald 2006 Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study Eur J Heart Fail 8 302 307
12. FA McAlister J Ezekowitz M Tonelli PW Armstrong 2004 Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study Circulation 109 1004 1009
13. JJ McMurray JR Teerlink G Cotter 2007 Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JAMA 298 2009 2019
14. MT Meinardi WT van der Graaf DJ van Veldhuisen JA Gietema EG De Vries DT Sleijfer 1999 Detection of anthracycline-induced cardiotoxicity Cancer Treat Rev 25 237 247
15. HR Neuberger C Mewis DJ van Veldhuisen 2007 Management of atrial fibrillation in patients with heart failure Eur Heart J 28 2568 2577
16. F Peters-Klimm T Muller-Tasch D Schellberg 2008 Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy Clin Res Cardiol 97 244 252
17. PA Poole-Wilson K Swedberg JG Cleland 2003 Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomised controlled trial Lancet 362 7 13
18. HB Sturm FM Haaijer-Ruskamp NJ Veeger CP Balje-Volkers K Swedberg WH van Gilst 2006 The relevance of comorbidities for heart failure treatment in primary care: a European survey Eur J Heart Fail 8 31 37
19. MH van der Wal T Jaarsma DK Moser NJ Veeger WH van Gilst DJ van Veldhuisen 2006 Compliance in heart failure patients: the importance of knowledge and beliefs Eur Heart J 27 434 440
20. DJ van Veldhuisen H Aass D El Allaf 2006 Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF study Eur J Heart Fail 8 539 546
21. R Willenheimer DJ van Veldhuisen B Silke 2005 Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III Circulation 112 2426 2435